FGF9 - fibroblast growth factor 9 Gene
Also Known as GAF; FGF-9; SYNS3; HBFG-9; HBGF-9
Species: Homo sapiens
About FGF9
This gene has 3 transcripts (splice variants), 129 orthologues, 21 paralogues and is associated with 3 phenotypes. Biased expression in kidney (RPKM 6.4), adrenal (RPKM 2.1) and 10 other tissues.
Summary
The protein encoded by this gene is a member of the Fibroblast Growth Factor (FGF) family. FGF Family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This protein was isolated as a secreted factor that exhibits a growth-stimulating effect on cultured glial cells. In nervous system, this protein is produced mainly by neurons and may be important for glial cell development. Expression of the mouse homolog of this gene was found to be dependent on Sonic Hedgehog (Shh) signaling. Mice lacking the homolog gene displayed a male-to-female sex reversal phenotype, which suggested a role in testicular embryogenesis. [provided by RefSeq, Jul 2008]
FGF9 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_002010.3 | NP_002001.1 | fibroblast growth factor 9 precursor |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| acts upstream of or within fibroblast growth factor receptor signaling pathway |
IGI
IGI: Inferred from genetic interaction
|
8663044 | GOA |
| involved in male gonad development |
IEP
IEP: Inferred from expression pattern
|
17848411 | GOA |
| acts upstream of or within positive regulation of cell population proliferation |
IDA
IDA: Inferred from direct assay
|
8321227 | GOA |
| involved in positive regulation of vascular associated smooth muscle cell proliferation |
IGI
IGI: Inferred from genetic interaction
|
29118903 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in extracellular space |
IDA
IDA: Inferred from direct assay
|
8321227 | GOA |
FGF9 Protein Structure
FGF: Fibroblast growth factor (62 - 188)
- 0
- 100
- 208 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
fibroblast growth factor 9 |
|
Recombinant FGF9 Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P7177 | FGF-9 Protein, Human | P31371 (M1-S208) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P73053 | FGF-9 Protein, Human (HEK293, Fc, solution) | NP_002001.1 (L4-S208) | ≥ 85%, as determined by reducing SDS-PAGE. |
| HY-P700071AF | Animal-Free FGF-9 Protein, Human (His) | P31371 (M1-S208) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P73053A | FGF-9 Protein, Human (HEK293, hFc) | NP_002001.1 (L4-S208) | ≥ 95%, as determined by reducing SDS-PAGE. |
FGF9 Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P811136 | FGF9 Antibody | WB, IHC-P | Human, Mouse, Rat |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Multiple Synostoses Syndrome 3 |
|
|
| Multiple Synostoses Syndrome |
|
|
| Apert Syndrome |
|
|
| Blastoma |
|
|
| Synostoses, Tarsal, Carpal, And Digital |
|
|
| Synostosis |
|
|
| Disorder Of Sexual Development |
|
|
| Craniosynostosis |
|
|
| Gonadal Dysgenesis |
|
|
| Spinal Stenosis |
|
|
| Muenke Syndrome |
|
|
| 46,Xx Sex Reversal |
|
|
| Bone Disease |
|
|
| Hypochondroplasia |
|
|
| 46,Xy Sex Reversal 2 |
|
|
| Lacrimoauriculodentodigital Syndrome |
|
|
| Thanatophoric Dysplasia, Type I |
|
|
| Proximal Symphalangism |
|
|
| Crouzon Syndrome |
|
|
| 46,Xy Sex Reversal |
|
|
| Breast Cancer |
|
|
| Cryptorchidism, Unilateral Or Bilateral |
|
|
| Osteochondrodysplasia |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Macaca mulatta | FGF9 | VGNC | VGNC:72650 |
| Rattus norvegicus | FGF9 | RGD | RGD:2610 |
| Mus musculus | FGF9 | MGD | MGI:104723 |
| Bos taurus | FGF9 | VGNC | VGNC:53814 |
| Felis catus | FGF9 | VGNC | VGNC:62257 |
| Canis familiaris | FGF9 | VGNC | VGNC:40854 |
| Others | FGF9 | NCBI |